glp-1 vision changes The Impact of Receptor Agonists on Ocular Disease GLP-1s Linked to Sudden, Rare

Description

Generic pre-op forms often only ask about regular medications, which patients skip because: Many do not count weight loss shots as medicine Some feel embarrassed about using weight loss drugs They simply do not know these matter to Anaesthetists AusDoc reported this trend last year in an article Anaesthetists forced to cancel procedures because of patients keeping quiet about GLP-1 receptor agonists

Binge eating disorder and night eating syndrome in adults with type 2 diabetes

For example, one clinical trial reported that 15.2 percent of participants experienced headaches after higher-dose semaglutide, compared to 12.2 percent of participants receiving a placebo (an inactive treatment)

Compared to alternate T2D drugs, GLP-1RAs have a unique adverse effect profile that necessitates individualized prescribing based on tolerability and risk factors

These are signs that the glucagon component is driving energy expenditure at a level that meaningfully contributes to the overall weight loss beyond what GLP-1 and GIP provide alone